EnglishEspañol

Mass Tort & Product Liability Lawsuits: Active Cases Directory (2026)

Independently fact-checked against primary sources (last audited September 14, 2026). · Law checked current as of August 8, 2026. · 21 primary sources cited on this page. How we verify our legal content

Mass Tort & Product Liability Lawsuits: Active Cases Directory (2026)

Frequently Asked Questions

What is the difference between a mass tort and a class action?

In a class action, many people are represented together and share one outcome. In a mass tort, each injured person keeps an individual lawsuit, often coordinated in one court (an MDL), so the result can reflect each person's specific injury.

What is an MDL?

A multidistrict litigation consolidates many similar federal lawsuits before a single judge for pretrial proceedings, including bellwether trials. It is not a class action; each case stays separate and can return to its home court for trial.

How do I know if I qualify for a mass tort claim?

There is no way to know from a website. Whether you may have a claim depends on the product or exposure, your injury, the timing, and your state's law. A licensed attorney can evaluate the specific facts, usually at no cost.

How much is a mass tort case worth?

There is no guaranteed amount, and any figure you see advertised is not a promise. Recoveries depend on the evidence, the injury, and the court. A verdict or settlement in one case does not set the value of another.

Is there a deadline to file?

Yes. Statutes of limitations vary by state and by claim type, and some run from when an injury is discovered. Missing the deadline usually bars the claim permanently, so it is worth checking early.

What happens to a mass tort when it settles or closes?

When a global settlement is reached or a court closes a litigation, firms usually stop taking new clients and remaining deadlines or appeals play out. People can still research closed torts, which is why this directory keeps dated status notes, but a closed or dismissed case generally is not a current claim opportunity.

Updates

Independently fact-checked against the cited primary sources

Governing law re-checked for recent changes

Sources and References

  1. U.S. Judicial Panel on Multidistrict Litigation (how MDLs are created)(uscourts.gov).gov
  2. U.S. Courts, Multidistrict Litigation overview(uscourts.gov).gov
  3. JPML, pending MDLs list(uscourts.gov).gov
  4. 28 U.S.C. 1407 (the MDL statute)(law.cornell.edu)
  5. JPML, MDL Statistics Report, Docket Summary Listing (Sept. 1, 2026), listing MDL 3191 (Non-AFFF Firefighter Turnout Gear, D. Minn.)(uscourts.gov).gov
  6. W.D. Pa., In re Philips Recalled CPAP (MDL 3014), Order Granting Final Approval of Medical Monitoring Class Settlement (Dec. 5, 2024)(uscourts.gov).gov
  7. Weed Killer Settlement, official court-appointed administrator site (settlement status and claim availability)(weedkillerclass.com)
  8. MassDevice, jury returns $88 million verdict in first Covidien hernia mesh bellwether (Aug. 2026)(massdevice.com)
  9. JPML, Distribution of Pending MDL Dockets by Actions Pending (September 1, 2026)(uscourts.gov).gov
  10. California Attorney General, $17 billion multistate settlement with Meta (August 26, 2026)(oag.ca.gov).gov
  11. In re Depo-Provera, MDL 3140 (N.D. Fla.), Case Management Order No. 13 appointing a settlement administrator (Aug. 5, 2026)(uscourts.gov).gov
  12. In re Camp Lejeune Water Litigation, No. 7:23-cv-897 (E.D.N.C.), Order Regarding Reappointment of Plaintiffs' Leadership Group (June 30, 2026)(camplejeunecourtinfo.com)
  13. In re Valsartan, Losartan, and Irbesartan Prods. Liab. Litig., MDL 2875 (D.N.J.), economic loss class settlement long form notice(sartanmedicationsettlement.com)
  14. AbbVie Inc., Form 10-Q for the quarter ended June 30, 2026 (BIOCELL and ALCL litigation)(sec.gov).gov
  15. Abbott, agreements resolving a portion of the preterm infant formula litigation (August 20, 2026)(abbott.mediaroom.com)
  16. Alabama Attorney General, $12.2 million settlement with Roblox (April 21, 2026)(alabamaag.gov).gov
  17. West Virginia Attorney General, settlement with Roblox (April 21, 2026)(ago.wv.gov).gov
  18. Combat Arms Earplug Settlement Program, official administrator site (funding schedule and payments issued)(combatarmssettlement.com)
  19. JPML, In re Future Motion, Inc. Products Liability Litigation, MDL No. 3087, Transfer Order (Dec. 8, 2023), centralizing the Onewheel actions in N.D. Cal. before Judge Beth Labson Freeman(uscourts.gov).gov
  20. JPML, In re Tasigna (Nilotinib) Products Liability Litigation, MDL No. 3006, Transfer Order (Aug. 10, 2021), centralizing the Tasigna actions in M.D. Fla. before Judge Roy B. Dalton(uscourts.gov).gov
  21. Defendants-Appellees' Petition for Rehearing or Rehearing En Banc, In re Acetaminophen - ASD/ADHD Products Liability Litigation, Nos. 24-916(L) et al. (2d Cir., filed Sept. 2026)(aboutlawsuits.com)
  22. JPML, In re Taxotere (Docetaxel) Eye Injury Products Liability Litigation, MDL No. 3023, Transfer Order (Feb. 1, 2022)(jpml.uscourts.gov).gov
  23. Becton, Dickinson and Company, Form 10-Q for the quarter ended June 30, 2026 (filed Aug. 6, 2026), Note 6 Contingencies(sec.gov).gov
  24. Consent Judgment, People of the State of California v. Meta Platforms, Inc., No. 4:23-cv-05448 (N.D. Cal. Aug. 26, 2026)(courtlistener.com)
  25. U.S. District Court, E.D. Pa., MDL 3163 (GLP-1 RAs NAION) orders, including Case Management Order No. 12 (July 2, 2026)(paed.uscourts.gov).gov
  26. Transcript of Pretrial Conference, E.D.N.C. Camp Lejeune litigation (Sept. 9, 2026)(camplejeunecourtinfo.com)
  27. GSK plc, Form 6-K (filed Sept. 8, 2026), Zantac litigation update(sec.gov).gov
  28. Docket, Inman v. Mead Johnson & Company, LLC, No. 1:22-cv-03737 (N.D. Ill.), entries 249 to 251(courtlistener.com)
  29. Docket, In re Future Motion, Inc. Products Liability Litigation, No. 5:23-md-03087 (N.D. Cal.)(courtlistener.com)
  30. U.S. District Court, N.D. Fla., In re Depo-Provera Products Liability Litigation, MDL 3140, case management orders by date(flnd.uscourts.gov).gov
  31. In re Depo-Provera (Depot Medroxyprogesterone Acetate) Prods. Liab. Litig., MDL No. 3140 (N.D. Fla.), Case Management Order No. 12 (July 27, 2026), recording the parties' representation that settlement registration should be completed in November 2026 with payments beginning to roll out by the first quarter of 2027(uscourts.gov).gov
  32. Teva Pharmaceutical Industries Limited, Form 10-Q for the period ended June 30, 2026, commitments and contingencies note stating that the first Georgia MDL Paragard bellwether trial concluded on February 3, 2026 with a defense verdict and that in July 2026 the court entered an order scheduling the second bellwether trial to begin April 12, 2027(sec.gov).gov
  33. Judicial Panel on Multidistrict Litigation, Transfer Order creating In re: Recalled Abbott Infant Formula Products Liability Litigation, MDL No. 3037 (filed Aug. 5, 2022), centralizing the actions in the Northern District of Illinois before Judge Matthew F. Kennelly(uscourts.gov).gov
Share: